R3i's House of MedTech portfolio company, Naluri Hidup, a Malaysia-headquartered digital health service provider, has closed a new funding round worth US$5 million, led by Singaporean VC firm Integra Partners.
Existing backers — strategic investors Duopharma Biotech and Pathology Asia, and VC firm M Venture Partners — also participated.
Sumitomo Corporation Equity Asia (Japan), Palm Drive Capital (New York), INP Capital (Vancouver), Hibiscus Fund (a VC fund managed by RHL Ventures and Korea’s KB Investment) also joined Naluri’s latest round.
Naluri will use the funds to expand operations in Singapore and Indonesia, as well as launch its service in Thailand and the Philippines.